# Hepatitis C Treatment Study in Myanmar

> **NCT03158857** · — · WITHDRAWN · sponsor: **Myanmar Oxford Clinical Research Unit**

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Sofosbuvir 400 mg

## Key facts

- **NCT ID:** NCT03158857
- **Lead sponsor:** Myanmar Oxford Clinical Research Unit
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01
- **Primary completion:** 2024-01
- **Final completion:** 2024-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Long local IRB process to meet with the treatment deadline
- **Last updated:** 2021-12-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03158857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03158857, "Hepatitis C Treatment Study in Myanmar". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03158857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*